Julio Licinio
Julio Licinio | |
|---|---|
Licinio in June 2006 | |
| Born | 1958 Belo Horizonte, Minas Gerais, Brazil |
| Nationality | American, Australian, Brazilian |
| Education | MD, Federal University of Bahia, 1982.
PhD, Psychiatry, Flinders University, 2017. MBA, Samuel Curtis Johnson Graduate School of Management, Cornell University, 2019. MS, Healthcare Leadership, Weill Cornell Graduate School of Medical Sciences, Cornell University, 2019. |
| Alma mater | Federal University of Bahia |
| Known for | Pharmacogenomics, biology of depression |
| Spouse | Ma-Li Wong |
| Scientific career | |
| Fields | Psychiatry |
| Institutions | Yale University, NIH Intramural Research Program, University of California, Los Angeles, University of Miami Miller School of Medicine, John Curtin School of Medical Research, South Australian Health and Medical Research Institute and Flinders University, State University of New York Upstate Medical University |
| Thesis | The biology of leptin: Effects on endocrine regulation and its replacement treatment (2017) |
Julio Licinio is an Australian American psychiatrist who is SUNY Distinguished Professor at State University of New York Upstate Medical University in Syracuse, New York. He is simultaneously Matthew Flinders Distinguished Professor of Psychiatry at Flinders University in Adelaide. Licinio has been Senior Vice President for Academic and Health Affairs, as well as Executive Dean, College of Medicine. Licinio is the founding and current chief editor of three journals from Springer Nature, Molecular Psychiatry, Translational Psychiatry, and Discover Mental Health.
His area of scientific expertise is precision medicine with a focus on pharmacogenomics, as well as the biology of depression, and he has edited books on both topics. He has also published research on translational psychiatry, as well as on obesity and the possible link between obesity, depression, and antidepressants.